Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 28, 2016; 22(16): 4211-4218
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4211
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4211
Variable | |
Age (yr) | 66 (38-88) |
Gender (M/F) | 88 (69.2%)/39 (30.8%) |
Absolute lymphocyte count (103 cells/μL) | 1.77 (0.45-5.98) |
Absolute neutrophil count (103 cells/μL) | 3.29 (0.98-12.17) |
Absolute monocyte count (103 cells/μL) | 0.35 (0.01-2.15) |
NLR (%) | 1.74 (0.33-13.09) |
LMR (%) | 4.38 (0.79-88) |
CEA (ng/mL) | 34.2 (1.5-1198) |
Number of Nodules | 2 (1-3) |
Max diameter (mm) | 27 (10-45) |
Primary tumor (colon/rectum) | 95 (74.8%)/32 (25.2%) |
Timing of occurrence (synchronous/metachronous) | 98 (77.1%)/29 (22.9%) |
ECOG performance status (0/1) | 112 (88.1%)/15 (11.9%) |
- Citation: Facciorusso A, Del Prete V, Crucinio N, Serviddio G, Vendemiale G, Muscatiello N. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. World J Gastroenterol 2016; 22(16): 4211-4218
- URL: https://www.wjgnet.com/1007-9327/full/v22/i16/4211.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i16.4211